Technical Analysis for ALDR - Alder BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 9.96 -1.48% -0.15
ALDR closed down 2.51 percent on Thursday, July 18, 2019, on 1.84 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ALDR trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness -1.48%
Multiple of Ten Bullish Other -1.48%
Below Lower BB Weakness -1.48%
Down 3 Days in a Row Weakness -1.48%
Down 4 Days in a Row Weakness -1.48%
Down 5 Days in a Row Weakness -1.48%
Lower Bollinger Band Touch Weakness -1.48%
Oversold Stochastic Weakness -1.48%
Hammer Candlestick Bullish -3.95%
Stochastic Reached Oversold Weakness -3.95%

Older signals for ALDR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Alder Biopharmaceuticals Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes various therapeutic antibodies in the United States and Australia. It is developing monoclonal antibodies comprising ALD403, which has completed Phase Ib proof-of-concept trials to target calcitonin gene-related peptide for the prevention of migraine; and Clazakizumab that has completed Phase IIb clinical trials that inhibits the pro-inflammatory cytokine interleukin-6 in the treatment of rheumatoid arthritis and psoriatic arthritis. The company also has preclinical programs in the discovery phase for various indications. Alder Biopharmaceuticals Inc. has a collaboration with Bristol-Myers Squibb Company for the development of Clazakizumab. Alder Biopharmaceuticals Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.
Medicine Biotechnology Health Biopharmaceutical Immunology Antibodies Monoclonal Antibodies Rheumatoid Arthritis Bristol Myers Squibb Migraine Prevention Of Migraine Psoriatic Arthritis
Is ALDR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.869
52 Week Low 9.44
Average Volume 876,069
200-Day Moving Average 12.5275
50-Day Moving Average 11.2876
20-Day Moving Average 11.257
10-Day Moving Average 11.093
Average True Range 0.5025
ADX 14.49
+DI 13.9312
-DI 35.0006
Chandelier Exit (Long, 3 ATRs ) 11.0225
Chandelier Exit (Short, 3 ATRs ) 11.2575
Upper Bollinger Band 12.1833
Lower Bollinger Band 10.3307
Percent B (%b) -0.12
BandWidth 16.457315
MACD Line -0.2497
MACD Signal Line -0.1129
MACD Histogram -0.1368
Fundamentals Value
Market Cap 684.58 Million
Num Shares 67.7 Million
EPS -5.14
Price-to-Earnings (P/E) Ratio -1.97
Price-to-Sales 1026.10
Price-to-Book 2.38
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.04
Resistance 3 (R3) 11.02 10.70 10.89
Resistance 2 (R2) 10.70 10.46 10.71 10.83
Resistance 1 (R1) 10.40 10.31 10.24 10.42 10.78
Pivot Point 10.08 10.08 10.00 10.09 10.08
Support 1 (S1) 9.78 9.84 9.62 9.80 9.44
Support 2 (S2) 9.46 9.69 9.47 9.39
Support 3 (S3) 9.16 9.46 9.34
Support 4 (S4) 9.18